4//SEC Filing
FRAGIN GARY S 4
Accession 0001179110-09-013629
CIK 0001107421other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:51 PM ET
Size
16.0 KB
Accession
0001179110-09-013629
Insider Transaction Report
Form 4
FRAGIN GARY S
Director
Transactions
- Award
Common Stock, $.001 par value
2009-09-23+30,000→ 45,000 total
Holdings
- 15,029
Director Stock Option (right to buy)
Exercise: $4.31Exp: 2014-12-22→ Common Stock, $.001 par value (15,029 underlying) - 20,000
Stock Option (right to buy)
Exercise: $2.73Exp: 2017-12-12→ Common Stock (20,000 underlying) - 15,000
Director Stock Option (right to buy)
Exercise: $5.01From: 2006-04-26Exp: 2016-04-26→ Common Stock (15,000 underlying) - 15,000
Director Stock Option (right to buy)
Exercise: $6.49Exp: 2016-12-13→ Common Stock (15,000 underlying) - 15,000
Stock Option (right to buy)
Exercise: $4.85Exp: 2017-06-18→ Common Stock (15,000 underlying) - 15,000
Stock Option (right to buy)
Exercise: $0.70Exp: 2019-05-13→ Common Stock (15,000 underlying)
Footnotes (6)
- [F1]7,515 shares vest on 12/22/05 and 7,514 shares vest on 12/22/06.
- [F2]5,000 shares vest on each of 12/13/07, 12/13/08 and 12/13/09.
- [F3]5,000 shares vest on each of 6/18/08, 6/18/09 and 6/18/10.
- [F4]6,667 shares vest on each of 12/12/08 and 12/12/09; 6,666 shares vest on 12/12/10.
- [F5]5,000 shares vest on each of 12/31/2009, 6/30/2010 and 12/31/2010.
- [F6]Grant of restricted stock; restrictions lapse on 9/23/2010.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001338534
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 4:51 PM ET
- Size
- 16.0 KB